Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
A Multi-site, Prospective, Observational Study of Autologous Hair Follicle Secretome (aHFS) as an Adjunct to Medical Aesthetic Procedures
1 other identifier
observational
500
2 countries
40
Brief Summary
Non-interventional, multi-site, prospective, open-label, observational, real-world study of autologous hair follicle secretome use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Typical duration for all trials
40 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2024
CompletedFirst Posted
Study publicly available on registry
June 27, 2024
CompletedStudy Start
First participant enrolled
September 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
March 4, 2026
March 1, 2026
2.4 years
June 21, 2024
March 2, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Post-Procedure Symptoms
Symptoms of redness, swelling, oozing, pain, tenderness, crusting, itching and discoloration will be measured using a 1-10 likert scale with 0 being best possible and 10 being worst imaginable.
1-7 days
Downtime Questionnaire
Questionnaire asking what activities would they have done, if it were not for their face appearance. Date of end of downtime captured.
1-7 days
Eligibility Criteria
The study population will be patients planning a medical aesthetic procedure and use of Autologous Hair Follicle Secretome cosmetic post-procedure.
You may qualify if:
- Male and Female
- Ages: 18-60
- Any Fitzpatrick skin type
- Planning a medical aesthetic procedure
- For subjects receiving hair procedures (closed to enrollment):
- Androgenic alopecia
- Traction alopecia
- Scarring alopecia
- Stable use of any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to enrollment in the study is allowed.
- No intention to start new hair growth medications or change dose of hair growth medications from the time of consent through the end of the study follow-up period.
- Undergoing one of the following medical aesthetic procedures:
- Laser resurfacing of the face (ablative or non-ablative) or Ellacor of the face (Ellacor closed to enrollment)
- Tixel of the face
- Keralase of the scalp (scalp treatment closed to enrollment)
- Acne Scars and Surgery scars, either old or new as long as old scars are also being treated with ablative or non-ablative laser or microneedling (e.g. abdominoplasty, breast reduction/ reconstruction/enhancement, post-weight loss, etc.
- +1 more criteria
You may not qualify if:
- Pregnant or Breastfeeding
- Participation in an interventional clinical trial in the last 30 days
- Use of other topical cosmetic products that may confound results
- Use of retinoids within 7 days prior to facial procedure
- For those receiving hair treatment, must not have had a hair transplant in the treatment area within the past 12 months
- Any health condition that in the investigator's opinion should preclude participation in study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (40)
Skin Wellness Dermatology
Birmingham, Alabama, 35209, United States
BelleSante
Scottsdale, Arizona, 85260, United States
Arash Moradzadeh MD
Beverly Hills, California, 90210, United States
Glenn Vallecillos, MD Inc
Beverly Hills, California, 90210, United States
Behr Laser & Skin Care Center
Fresno, California, 93720, United States
Aesthetics By Dr. Lee
Granite Bay, California, 95746, United States
Carlo Honrado, MD, FACS
Los Angeles, California, 90067, United States
Marcus Medical
Manhattan Beach, California, 90266, United States
N2 Aesthetics
Manhattan Beach, California, 90266, United States
Marina Plastic Surgery
Marina del Rey, California, 90292, United States
M Beauty by Tess
San Diego, California, 92126, United States
Modern Aesthetics
Walnut Creek, California, 94598, United States
Dr. Christie
West Hollywood, California, 90069, United States
Ziering Medical
West Hollywood, California, 90069, United States
BEAUTY by BUFORD
Lone Tree, Colorado, 80124, United States
Bauman Medical
Boca Raton, Florida, 33432, United States
Mirror Plastic Surgery
St. Petersburg, Florida, 33701, United States
Hive Aesthetic LLC
Chicago, Illinois, 60657, United States
Chernoff Cosmetic Surgery
Indianapolis, Indiana, 46220, United States
ICON Antiaging & Aesthetics
Birmingham, Michigan, 48009, United States
Davis Cosmetic Plastic Surgery
Cherry Hill, New Jersey, 08003, United States
AIEREM Aesthetics Spa & Plastic Surgery
Manhattan, New York, 75231, United States
Lewis Dermatology and Associates
New York, New York, 10021, United States
Unger Medical Hair Transplant Clinic
New York, New York, 10021, United States
SkinLabRx
New York, New York, 10028, United States
Sadick Dermatology
New York, New York, 10075, United States
AIEREM Aesthetics Spa & Plastic Surgery
Syosset, New York, 11791, United States
Austin Plastic Surgeon
Austin, Texas, 78758, United States
Dallas Plastic Surgery Institute
Dallas, Texas, 75225, United States
US Dermatology Partners / Dermatology Associates of Tyler
Tyler, Texas, 75703, United States
AG Aesthetic Centre
Vancouver, Washington, 98660, United States
Dr. Jean Carruthers Cosmedic
Vancouver, British Columbia, V5Z 4E1, Canada
Dr. Amber Bocknek
Aurora, Ontario, L4G1B9, Canada
Sanjeev Goel MD Peak Human
Brampton, Ontario, L6W 3E1, Canada
Compass Dermatology
Toronto, Ontario, M4S 2N5, Canada
Rejuuv
Toronto, Ontario, M5R 0C7, Canada
Dr. Nowell Solish Cosmetic Dermatologist
Toronto, Ontario, M5R 3N8, Canada
FCP Dermatology
Toronto, Ontario, M5X 1A9, Canada
BeSpoke Wellness
Toronto, Ontario, Canada
Clinique Antiaging
Montreal, Quebec, H3A 1S2, Canada
Study Officials
- STUDY CHAIR
Drew Taylor, PhD
Acorn Biolabs
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2024
First Posted
June 27, 2024
Study Start
September 9, 2024
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
March 4, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share